Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Ultrasound System Treats Neurological Disorders in the Brain

By HospiMedica International staff writers
Posted on 31 Dec 2012
A novel transcranial focused ultrasound system treats neurological disorders in the brain, including essential tremor, Parkinson’s disease (PD), and neuropathic pain.

The ExAblate Neuro system is based on magnetic resonance guided Focused ultrasound (MRgFUS) technology, which combines a high intensity focused ultrasound beam that noninvasively heats and destroys targeted tissue, together with a magnetic resonance imaging (MRI) system which visualizes patient anatomy in 3 orientations for precise tumor targeting, and controls the treatment by continuously monitoring the tissue effect. More...
The precise anatomical MRI shows the tumor and surrounding organs, and are used to position the patient and to plan the treatment to ensure exact tumor targeting.

MRI guidance and control also provide beam path visualization for controlled treatment (since the focused ultrasound beam can be seen during the treatment, ensuring that the ultrasound travels through a safe pathway to the focus), MR thermometry for real-time and continuous temperature feedback (allowing the physician to see temperature changes in the tumor during treatment), and post-treatment contrast imaging for precise treatment validation. The temperature maps are displayed as a color map superimposed on the anatomical MRI image; this allows the physician to observe temperature changes continuously during treatment.

The ExAblate device itself consists of a helmet-like apparatus with thousands of individual ultrasound elements powered by a phased array transducer. Since the high ultrasound absorption in bone results in an increase in bone temperature, which may result in brain-tissue coagulation near the skull, chilled water is constantly circulated around the skull during the treatment. Additionally, since the skull has a variable thickness and density, which causes the ultrasound beam to become defocused, CT images are used to reconstruct the skull for targeting. The ExAblate Neuro system is a product of InSightec (Tirat Carmel, Israel), and has received the European Community CE marking of approval.

“Because of its targeting accuracy, real time treatment monitoring, and ability to provide noninvasive brain treatment, there is hope that many people who suffer from neurological diseases can benefit from this treatment,” said Kobi Vortman, MD, President of InSightec. “Results from the clinical studies showed that patients, many of whom who suffered for years from neurological disorders, experienced immediate symptom improvement with a high safety profile. These patients are now better able to conduct activities of daily living and are also less dependent on external caregiver support.”

Related Links:

InSightec



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.